Skip to main content

Leica Biosystems News

Updates about Leica Biosystems.

csm_Leica_Biosystems
Published: 3 April 2023

The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments. NEWCASTLE, UK – Leica Biosystems today announced the US Food and Drug Administration (FDA) 510(k) clearance of the BOND MMR Antibody Panel, providing customers…

csm_Leica_Biosystems
Published: 13 March 2023

Leica Biosystems to adopt Paige's image management and AI system for sale with Leica Biosystems Aperio digital pathology slide scanners NEW YORK and VISTA, Calif. – March 13, 2023 – Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, and Leica Biosystems,…

csm_Leica_Biosystems
Published: 9 December 2022

The history of Leica Biosystems is a history of science and technology innovation. For 150+ years, we’ve tackled pathology challenges head on – from company founder Rudolf Jung building the first microtome to today’s world-leading Digital Pathology empowering AI development. No other global company…

csm_Leica_Biosystems
Published: 18 November 2022

VISTA, Calif. (18, 2022) – Pathologists from more than 23 countries are engaged on more than 35 discussion threads on Digital Pathology Connections (DPC), a global community for professionals interested in the digital future of the anatomic pathology laboratory. Pathology professionals everywhere…